Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2025-07-15
2027-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Developing a Culturally Adapted Intervention for Latino Youth Transitioning to Adulthood
NCT06107972
Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders
NCT04788537
Daily Living Skills Intervention for Adolescents With Autism Spectrum Disorder
NCT03984487
Intervention for Toddlers at Risk for Autism Spectrum Disorders (ASD)
NCT01179841
Improving Social Interaction for Adolescents With Autism During the Transition to Adulthood
NCT03785327
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Launching! to adulthood group therapy
Launching! to adulthood group therapy
Participants will be in a 12-week therapy program that includes weekly group sessions and individual coaching.
No intervention then Launching! to adulthood group therapy
Launching! to adulthood group therapy
Participants will be in a 12-week therapy program that includes weekly group sessions and individual coaching.
standard of care
Participants will receive a list of resources
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Launching! to adulthood group therapy
Participants will be in a 12-week therapy program that includes weekly group sessions and individual coaching.
standard of care
Participants will receive a list of resources
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* score of \>14 on the Social Communication Questionnaire-Lifetime (SCQ-L) completed with the mother or father
* meet DSM-5 criteria for ASD based on a Diagnostic and Statistical Manual of Mental Disorders (DSM-5) ASD symptom checklist
* willing and motivated to participate in the treatment
* a parent willing to participate
* verbal intelligence quotient (IQ) score \>70 as assessed by the Kaufman Brief Intelligence Test 2nd edition revised (KBIT-2-R)
Exclusion Criteria
* suicidal ideation with intent or plan
* current alcohol or other substance use disorder rated severe
* concurrent enrollment in another clinical trial for autism spectrum disorder
* expression of unwillingness to complete study procedures
18 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Pagan
Postdoctoral Research Fellow II
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonio Pagan, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-MS-25-0098
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.